The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
Опубликовано в: : | BMC Anesthesiology 22(2022)S. 12 |
---|---|
Главные авторы: | Unterberg, Matthias (Автор), Rahmel, Tim (Автор), Köhler, Thomas (Автор), Henzler, Dietrich (Автор), Schwier, Elke (Автор) |
Формат: | Статья |
Язык: | English |
Опубликовано: |
2022
|
Предметы: | |
Online-ссылка: | https://doi.org/10.1186/s12871-021-01547-8 |
Связанные документы: | In:
BMC Anesthesiology |
Схожие документы
-
Dosing of Antimycotic Treatment in Sepsis-Induced Liver Dysfunction by Functional Liver Testing with LiMAx
по: Kirchner, Carmen, и др.
Опубликовано: (2019) -
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
по: Köhler, Thomas, и др.
Опубликовано: (2021) -
Interrupted Chain of Transmission in a Pediatric COVID-19 Case
по: Grautoff, Steffen
Опубликовано: (2020) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
по: Köhler, Thomas, и др.
Опубликовано: (2022) -
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
по: Schwier, Elke, и др.
Опубликовано: (2021)